Clinical Trial Update: A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations [Phase 3]

View source ↗

Summary

Phase 3 multicenter trial evaluating the efficacy and safety of PEP005 (ingenol mebutate) gel for actinic keratosis on non-head locations; results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• PEP005 (Ingenol Mebutate) Gel (Ingenol mebutate)

Snippet

Sponsor: Peplin | Conditions: Actinic Keratoses | Phase 3 | Status: COMPLETED | Results posted: 2012-03-19